Manganese

Umxholo

• Ukusebenza ...
• Akukho bungqina baneleyo bokulinganisa ukusebenza ...
• Amanyathelo okhuseleko kunye nezilumkiso:

I-Manganese yiminerali efumaneka kukutya okuninzi kubandakanya amandongomane, iimbotyi, iimbewu, iti, ukutya okuziinkozo kunye nemifuno eluhlaza. Kucatshangelwa njengesondlo esibalulekileyo, kuba umzimba ufuna ukuba usebenze ngokufanelekileyo. Abantu basebenzisa i manganese njengeyeza.

Imanganizi isetyenziselwa ukusilela kwe manganese. Isetyenziselwa amathambo abuthathaka kunye nophuka amandla (i-osteoporosis), i-osteoarthritis, kunye nezinye iimeko, kodwa abukho ubungqina benzululwazi obuxhasa ezi zinto zisetyenziswayo.

Amayeza endalo aVimba weDatha Ukusebenza kwexabiso ngokusekwe kubungqina besayensi ngokwala manqanaba alandelayo: Ukusebenza, ukusebenza ngokukuko, okunokwenzeka ukuba kusebenze, okungenzeka kungasebenzi, kunokwenzeka ukungasebenzi, ukungasebenzi, kunye nobungqina obungonelanga bokulinganisa.

Ukulinganiswa kokusebenza kwe MANGANESE zezi zilandelayo:

Ukusebenza ...

• Ukusilela kweManganese. Ukuthatha i-manganese ngomlomo okanye ukunika imanganizi ngaphakathi (nge-IV) kuyanceda ukunyanga okanye ukuthintela amanqanaba emanganizi asezantsi emzimbeni. Kwakhona, ukuthatha i-manganese ngomlomo kunye nezinye iivithamini kunye neeminerali kunokukhuthaza ukukhula kubantwana abanamanqanaba asezantsi e-manganese kumazwe asaphuhlayo.

Akukho bungqina baneleyo bokulinganisa ukusebenza ...

• Yewena mkhuhlane. Ukusebenzisa isitshizi samanzi setyuwa samanzi nge-manganese eyongeziweyo kubonakala ngathi kunciphisa iziqendu ze-hay fever, kodwa isitshizi samanzi esetyuwa sinokusebenza ngokufanayo.
• Isifo semiphunga esenza ukuba kube nzima ukuphefumla (isifo esinganyangekiyo semiphunga okanye isifo seCOPD). Uphando lwakwangoko lubonisa ukuba ukunika i-manganese, i-selenium, kunye ne-zinc nge-intravenously (nge-IV) kunokunceda abantu abane-COPD eyandayo ukuba baziphefumle ngaphandle koncedo kumatshini kwangoko.
• Iintsana ezizalwe zinobunzima obungaphantsi kwama-2500 gram (iiponti ezi-5, ii-ounces eziyi-8). Olunye uphando lufumanise ukuba abasetyhini abanamanqanaba e-manganese aphezulu kakhulu okanye aphantsi kakhulu banokuba nethuba eliphezulu lokuhambisa iintsana ezingamadoda ezinobunzima bokuzalwa obuphantsi. Kwakungekho njalo kubantwana ababhinqileyo. Akucaci ukuba uthatha isongezo se manganese ngelixa ukhulelwe unokunceda ukuthintela ubunzima bokuzalwa obuphantsi emadodeni.
• Ukutyeba kakhulu. Uphando lwakwangoko lubonisa ukuba ukuthatha imveliso ethile equlathe i manganese, 7-oxo-DHEA, L-tyrosine, asparagus root extract, choline bitartrate, inositol, copper gluconate, kunye ne potassium iodide ngomlomo iiveki ezisibhozo kungabunciphisa kancinci ubunzima kubantu abatyebe kakhulu. Akucaci ukuba ukuthatha i-manganese kuphela kunefuthe kubunzima.
• Osteoarthritis. Ukuthatha imveliso ethile ene-manganese, i-glucosamine hydrochloride, kunye ne-chondroitin sulphate ngomlomo kangangeenyanga ezi-4 ziphucula iintlungu kunye nokukwazi ukwenza imisebenzi yesiqhelo kubantu abane-osteoarthritis yamadolo kunye nomqolo osezantsi. Nangona kunjalo, uninzi lwezifundo lubonisa ukuba ukuthatha i-glucosamine kunye ne-chondroitin ngaphandle kwe-manganese kunokunceda ukunyanga i-osteoarthritis. Ke ngoko, iimpembelelo ze manganese azicacanga.
• Amathambo abuthathaka kunye nophuko (i-osteoporosis). Ukuthatha i-manganese ngomlomo ngokudibeneyo ne-calcium, i-zinc, kunye nobhedu kunciphisa ukulahleka kwethambo lomqolo kubafazi abadala. Kwakhona, ukuthatha imveliso ethile equkethe i-manganese, i-calcium, i-vitamin D, i-magnesium, i-zinc, ithusi kunye ne-boron unyaka omnye kubonakala ngathi kuphucula ubunzima bethambo kubafazi abanamathambo abuthathaka. Nangona kunjalo, uninzi lwezifundo lubonisa ukuba ukuthatha i-calcium kunye ne-vitamin D ngaphandle kwe-manganese kunokunceda ukunyanga i-osteoporosis. Ke ngoko, iimpembelelo ze manganese azicacanga.
• Isifo se-Premenstrual syndrome (PMS). Uphando lwakwangoko lubonisa ukuba ukuthatha i-manganese kunye ne-calcium kunceda ekuphuculeni iimpawu ze-PMS, kubandakanya iintlungu, ukukhala, isizungu, unxunguphalo, ukuphumla, ukuba nochuku, ukutshintsha kweemvakalelo, uxinzelelo kunye noxinzelelo. Abaphandi abaqinisekanga ukuba ukuphuculwa kubangelwa yi-calcium, i-manganese, okanye indibaniselwano.
• Iintsana ezinobunzima bokuzalwa ngaphantsi kwe-10 percentile. Olunye uphando lufumanise ukuba abasetyhini abanamanqanaba e-manganese aphezulu kakhulu okanye aphantsi kakhulu banokuba nethuba eliphezulu lokuhambisa iintsana zamadoda ezinobunzima bokuzalwa ngaphantsi kwe-10^th ipesenti Kwakungekho njalo kubantwana ababhinqileyo. Akucaci ukuba uthatha isongezo se manganese ngelixa ukhulelwe unokunceda ukuthintela ubunzima bokuzalwa obuphantsi emadodeni.
• Ukuphilisa amanxeba. Uphando lwakwangoko lubonisa ukuba ukufaka into yokunxiba ene-manganese, calcium, kunye ne-zinc kwizilonda ezingapheliyo zeeveki ezili-12 kunokuphucula ukuphola kwenxeba.
• Ukunqongophala kwegazi.
• Ezinye iimeko.

Ubungqina obungakumbi buyafuneka ukukala ukusebenza kwe manganese kwezi zinto zisetyenziswayo.

Imanganizi sisondlo esibalulekileyo esichaphazelekayo kwiinkqubo ezininzi zamachiza emzimbeni, kubandakanya ukuqhubekeka kwecholesterol, iikhabhohayidrethi kunye neeproteni. Inokuthi ibandakanyeke ekwakheni amathambo.

Xa kuthathwa ngomlomo: Manganese yi NGOKUKHUSELEKILEYO kubantu abadala abaninzi xa bethathwe ngomlomo izixa ukuya kuthi ga kwi-11 mg ngosuku. Nangona kunjalo, abantu abanengxaki yokususa i-manganese emzimbeni, njengabantu abanesifo sesibindi, banokufumana iziphumo ebezingalindelekanga xa bethatha ngaphantsi kwe-11 mg ngosuku. Ukuthatha ngaphezulu kwe-11 mg ngosuku ngomlomo OKUNGENZEKA UKHUSELEKILE uninzi lwabantu abadala.

Xa unikwe ngu-IV: Manganese yi NGOKUKHUSELEKILEYO xa inikwa yi-IV njengenxalenye yesondlo sabazali phantsi kweliso lomboneleli wezempilo. Kucetyiswa ngokubanzi ukuba isondlo sabazali asiboneleli ngaphezulu kwe-55 mcg ye-manganese ngosuku, ngakumbi xa isetyenziswa ixesha elide. Ukufumana ngaphezulu kwe-55 mcg yemanganizi ngosuku nge-IV njengenxalenye yesondlo se-parenteral OKUNGENZEKA UKHUSELEKILE uninzi lwabantu abadala.

Xa uphefumlelwe: Manganese yi NGOKUFANELEKILEYO xa uphefumlelwe ngabantu abadala ixesha elide. Ukugqithisa kwe manganese emzimbeni kunokubangela iziphumo ebezingalindelekanga ezibi, kubandakanya impilo enkenenkene yethambo kunye neempawu ezifana nesifo seParkinson, njengokungcangcazela (ukungcangcazela).

Amanyathelo okhuseleko kunye nezilumkiso:

Abantwana: Ukuthatha i-manganese ngomlomo NGOKUKHUSELEKILEYO kubantwana abaneminyaka eyi-1 ukuya kwe-3 kwimali engaphantsi kwe-2 mg ngosuku; kubantwana abaneminyaka emi-4 ukuya kwe-8 ngemali engaphantsi kwe-3 mg ngosuku; kubantwana abaneminyaka eli-9 ukuya kweli-13 kwimali engaphantsi kwe-6 mg ngosuku; kwaye kubantwana abaneminyaka eli-14 ukuya kweli-18 ngesixa esingaphantsi kwe-9 mg ngosuku. Imanganizi ngeedosi eziphezulu kunokuba kuchaziwe OKUNGENZEKA UKHUSELEKILE. Thetha nomboneleli wakho wezempilo ngaphambi kokuba unike abantwana i-manganese. Iidosi eziphezulu ze manganese zinokubangela iziphumo ebezingalindelekanga ezibi. Imanganizi yiyo NGOKUFANELEKILEYO xa uphefumlelwe ngabantwana.

Ukukhulelwa kunye nokuncancisa: Manganese yi NGOKUKHUSELEKILEYO kubasetyhini abakhulelweyo okanye abancancisayo abaneminyaka eyi-19 okanye ngaphezulu xa bethathwe ngomlomo ngeedosi ezingaphantsi kwe-11 mg ngosuku. Nangona kunjalo, abasetyhini abakhulelweyo nabancancisayo abaneminyaka engaphantsi kwe-19 kufuneka banciphise idosi ukuya ngaphantsi kwe-9 mg ngosuku. Imanganizi yiyo OKUNGENZEKA UKHUSELEKILE xa ithathwa ngomlomo kwiidosi eziphezulu. Imithamo engaphezulu kwe-11 mg ngemini inokubangela iziphumo ebezingalindelekanga ezibi. Ukuthatha i-manganese kakhulu kunokunciphisa ubungakanani bokuzalwa kweentsana ezingamadoda. Imanganizi yiyo NGOKUFANELEKILEYO xa uphefumlelwe ngabafazi abakhulelweyo okanye abancancisayo.

Isifo sesibindi sexesha elide: Abantu abanesifo sesibindi sexesha elide banengxaki yokususa imanganese. Imanganizi inokwakha kwaba bantu kwaye ibangele ukugungqa, iingxaki zengqondo ezinje ngengqondo, kunye nezinye iziphumo ebezingalindelekanga. Ukuba unesifo sesibindi, lumka ungafumani manganese kakhulu.

Ukunqongophala kwe-iron anemia: Abantu abane-anemia yokunqongophala kwe-iron babonakala befunxa i-manganese ngakumbi kunabanye abantu. Ukuba unale meko, lumka ukuba ungafumani manganese kakhulu.

Isondlo esinikwa ngaphakathi (nge-IV). Abantu abafumana ukutya okunesondlo ngaphakathi (nge-IV) basemngciphekweni omkhulu weziphumo ebezingalindelekanga ngenxa yemanganizi.

Iphakathi

Lumka ngale nhlanganisela.

Iintsholongwane (iquinolone antibiotics)

I-Manganese inokuncamathela kwii-quinolones esiswini. Oku kunciphisa inani leequinolones ezinokufunxwa ngumzimba. Ukuthatha i-manganese kunye neequinolones kunokunciphisa ukusebenza kwazo. Ukuthintela oku kunxibelelana, thatha izongezo ze manganese ubuncinci iyure enye emva kwee-quinolone antibiotics.
Ezinye iiquinolones zibandakanya i-ciprofloxacin (Cipro), gemifloxacin (Factive), levofloxacin (Levaquin), moxifloxacin (Avelox), kunye nezinye.

Iintsholongwane (iTetracycline antibiotics)

Imanganisi inokuncamathela kwiitetracyclines esiswini. Oku kunciphisa inani leetetracyclines ezinokufunxwa ngumzimba. Ukuthatha i-manganese nge-tetracyclines kunokunciphisa ukusebenza kweetetracyclines. Ukuthintela oku kunxibelelana, thatha i-manganese kwiiyure ezimbini ngaphambi okanye kwiiyure ezine emva kokuthatha i-tetracyclines.

Ezinye i-tetracyclines zibandakanya i-demeclocycline (iDeclomycin), i-minocycline (iMinocin), kunye ne-tetracycline (Achromycin).

Amayeza ezimo zengqondo (iziyobisi ezichasene nengqondo)

Amachiza okunyanga i-antipsychotic athathwa ngabanye abantu ukunyanga izifo zengqondo. Abanye abaphandi bakholelwa ukuba ukuthatha amayeza athile okunyanga i-antipsychotic kunye ne-manganese kunokuba mandundu kwimiphumela ye-manganese kwabanye abantu.

Ikhalsiyam

Ukuthatha i-calcium kunye ne-manganese kunokunciphisa inani le-manganese elinokuthathwa ngumzimba.

IP-6 (iPhytic acid)

I-IP-6 efumaneka ekutyeni, okufana ne-cereal, amandongomane, kunye neembotyi, kunye nakwizincedisi zinganciphisa inani leemanganizi ezithathwa ngumzimba. Thatha imanganizi okungenani iiyure ezimbini phambi okanye kwiiyure ezimbini emva kokutya ukutya okune-IP-6.

Intsimbi

Ukuthatha i-iron kunye ne-manganese kunganciphisa inani le-manganese elinokuthathwa ngumzimba.

Izinki

Ukuthatha i-zinc kunye ne manganese kungonyusa inani lemanganizi elinokuthathwa ngumzimba. Oku kungonyusa iziphumo ebezingalindelekanga zemanganizi.

Amafutha

Ukutya amanqatha asezantsi kunokunciphisa ukuba manganese kangakanani umzimba onokuwuthatha.

Ubisi lweprotheni

Ukongeza iiprotein zobisi ekudleni kunokunyusa inani lemanganizi umzimba unokulifunxa.

La machiza alandelayo afundwe kuphando lwezesayensi:

ABADALA
NGOMLOMO:

• Ngokubanzi: Akukho zibonelelo zokutya zicetyiswayo (i-RDA) zeemanganizi esekwe. Xa kungekho zi-RDAs zesondlo, iNtlanganisela eyaneleyo (AI) isetyenziswa njengesikhokelo. I-AI lixabiso eliqikelelweyo lesondlo esisetyenziswa liqela labantu abasempilweni kwaye kucingelwa ukuba lanele. Amanqanaba okutya okwaneleyo (AI) yemihla ngemihla yemanganizi ngala: amadoda aneminyaka eli-19 nangaphezulu, i-2.3 mg; abafazi 19 nangaphezulu, 1.8 mg; abafazi abakhulelweyo abaneminyaka eli-14 ukuya kwengama-50, 2 mg; Abasetyhini abancancisayo, i-2.6 mg.
• Amanqanaba okuThoba aPhezulu anganyamezelekiyo (i-UL), elona nqanaba liphezulu lokutya apho iziphumo ebezingalindelekanga ezingalindelekanga, kuba imanganese sele zimiselwe. Ii-UL zemihla ngemihla zemanganese zezi: kubantu abadala abaneminyaka eli-19 nangaphezulu (kubandakanya nabasetyhini abakhulelweyo nabancancisayo), i-11 mg.

NGU-IV:

• Kwinqanaba eliphantsi le manganese emzimbeni (ukusilela kwe manganese)Ukuthintela ukunqongophala kwe-manganese kubantu abadala, isondlo esipheleleyo se-parenteral esine-200 mcg ye-manganese elemental ngemini isetyenzisiwe. Idosi yemihla ngemihla yemanganizi ekusetyenzisweni kwexesha elide kwesondlo esipheleleyo se-parenteral yi-55 mcg ngosuku.

ABANTWANA
NGOMLOMO:

• Ngokubanzi: Akukho zibonelelo zokutya zicetyiswayo (i-RDA) zeemanganizi esekwe. Xa kungekho zi-RDAs zesondlo, iNtsebenzo eyaneleyo (AI) isetyenziswa njengesikhokelo. I-AI lixabiso eliqikelelweyo lesondlo esisetyenziswa liqela labantu abasempilweni kwaye kucingelwa ukuba lanele. Kubantwana nasebantwaneni, amanqanaba e-Intake ngokwaneleyo yokuNcitshiswa (i-AI) yemanganese ngala: ziintsana ezizalwa ukuya kwiinyanga ezi-6, i-3 mcg; Iinyanga ezi-7 ukuya kwezi-12, i-600 mcg; abantwana abaneminyaka eyi-1 ukuya kwe-3, 1.2 mg; Iminyaka emi-4 ukuya kweli-8 1.5 mg; amakhwenkwe aneminyaka eli-9 ukuya kweli-13, 1.9 mg; amakhwenkwe aneminyaka eli-14 ukuya kweli-18, 2.2 mg; kunye namantombazana aneminyaka eli-9 ukuya kweli-18, 1.6 mg. Amanqanaba okuThoba aPhezulu anganyamezelekiyo (i-UL), elona nqanaba liphezulu lokutya apho iziphumo ebezingalindelekanga ezingalindelekanga, kuba imanganese sele zimiselwe. Ii-uls zemihla ngemihla ze manganese yabantwana zezi: abantwana abaneminyaka eli-1 ukuya kwengu-3, ​​2 mg; Iminyaka emi-4 ukuya kweli-8, 3 mg; Iminyaka eli-9 ukuya kweli-13, 6 mg; kunye ne-14 ukuya kwi-18 iminyaka (kubandakanya nabasetyhini abakhulelweyo nabancancisayo), 9 mg.

NGU-IV:

• Kwinqanaba eliphantsi le manganese emzimbeni (ukusilela kwe manganese)Ukuthintela ukunqongophala kwe-manganese ebantwaneni, isondlo esipheleleyo se-parenteral esine-2-10 mcg okanye ukuya kwi-50 mcg ye-manganese elemental ngemini isetyenzisiwe.

Aminoate de Manganèse, Ascorbate de Manganèse, Chlorure de Manganèse, Citrate de Manganèse, Complexe Aspartate de Manganèse, Dioxyde de Manganèse, Gluconate de Manganèse, Glycérophosphate de Manganèse, Manganèse, Manganese Amateyinate, Manganese Amateyinate manganese chloride, manganese Chloridetetrahydrate, manganese Citrate, dioxide manganese, manganese Gluconate, manganese Glycerophosphate, manganese Sulfate, manganese Sulfate Monohydrate, manganese Sulfate Tetrahydrate, Manganeso, Manganum, MN, Monohydrate de Sulfate de manganese, Sulfate de manganese.

Ukuze ufunde okungakumbi malunga nokubhalwa kweli nqaku, nceda ubone Amayeza endalo aVimba weDatha indlela yokusebenza.

1. U-Li D, uGe X, uLiu Z, et al. Umanyano phakathi kwexesha elide lokuvezwa kwe manganese kunye nomgangatho wethambo phakathi kwabasebenzi abathathe umhlala-phantsi. I-Environ Sci Pollut Res Int 2020; 27: 482-9. Jonga i-abstract.
2. Yamamoto M, Sakurai K, Eguchi A, et al .; IJapan Indalo kunye neQela lokuFunda laBantwana: Umbutho phakathi kwenqanaba le-manganese yegazi ngexesha lokukhulelwa kunye nobungakanani bokuzalwa: imeko-bume yaseJapan kunye nesifundo sabantwana (JECS). I-Environ Res 2019; 172: 117-26. Jonga i-abstract.
3. UKresovich JK, uBulka CM, uJoyce BT, et al. Amandla okuvuvukala kweemanganizi zokutya kwiqela labantu abadala. Uluhlu lweBiol Trace Elem Res 2018; 183: 49-57. ikhonkco: 10.1007 / s12011-017-1127-7. Jonga i-abstract.
4. IGrasso M, deVincentiis M, Agolli G, Cilurzo F, Grasso R.Ukusebenza kwekhosi yexesha elide le-Sterimar Mn ngeempumlo zempumlo kunyango lwamazinga aphindaphindiweyo e-aleji erhinitis egulayo kwizigulana ezinesifo esinganyangekiyo se-rhinitis. Iziyobisi Des Desvel Ther 2018; 12: 705-9. ikhonkco: 10.2147 / DDDT.S145173. Jonga i-abstract.
5. . I-Ho CSH, i-Ho RCM, kunye ne-Quek AML. Ityhefu engapheliyo ye-manganese enxulunyaniswa ne-voltage-gated ye-potassium ye-antibodies ezintsonkothileyo kwisifo se-neuropsychiatric. I-Int J En Res Res yezeMpilo yoLuntu i-2018; 15. IPH: E783. ikhonkco: 10.3390 / ijerph15040783. Jonga i-abstract.
6. U-Baker B, u-Ali A, u-Isenring L. Iingcebiso zokongezwa kwe manganese kwizigulana zabantu abadala ezifumana isondlo sexesha elide ekhaya: Uhlalutyo lobungqina obuxhasayo. Ukusebenza kweKlinikhi yeNutr 2016; 31: 180-5. ikhonkco: 10.1177 / 0884533615591600. Jonga i-abstract.
7. Schuh MJ. Isifo sikaParkinson esinokwenzeka esibangelwa kukungenisa okungapheliyo kwemanganese. Nxibelelana noFarm. Ngo-2016; 31: 698-703. ikhonkco: 10.4140 / TCP.n.2016.698. Jonga i-abstract.
8. UVanek VW, uBorum P, uBuchman A, et al. I-A.S.P.E.N. iphepha lokuma: izindululo zotshintsho kwimveliso ye-multivitamin ye-parenteral kunye nentengiso yemveliso eyahlukeneyo. Ukuziqhelanisa neKlinikhi yeNutr.Ngo-2012; 27: 440-491 10.10177 / 0884533612446706 (jonga apha).
9. U-Sayre EV, uSmith RW. Iindidi zeglasi yakudala. Inzululwazi 1961; 133: 1824-6. Jonga i-abstract.
10. UChalmin E, uVignaud C, uSolomon H, et al. Amaminerali afunyenwe kumbala omnyama wePaleolithic ngokudlulisa i-electron microscopy kunye ne-micro-X-ray yokuxutywa kwesakhiwo. I-Physics esetyenzisiweyo A 2006; 83: 213-8.
11. UZenk, uJ. Uphando lwangoku lonyango (i-CURR THER RES) 2002; 63: 263-272.
12. Wada, O. kunye no-Yanagisawa, H. [Landa izinto kunye nendima yabo yomzimba]. UNippon Rinsho 1996; 54: 5-11. Jonga i-abstract.
13. USalducci, uJ kunye no-Planche, D. [Uvavanyo lwezonyango kwizigulana ezine-spasmophilia]. Sem.Hop. 10-7-1982; 58: 2097-2100. Jonga i-abstract.
14. I-Kies, C. V. Ukusetyenziswa kwezimbiwa kwabatyayo: ifuthe lokwahluka kukutya kwamafutha. NdinguJ J Clin Nutriti 1988; 48 (3 Suppl): 884-887. Jonga i-abstract.
15. USaudin, F., uGelas, uP., Kunye noBouletreau, P. [Landa izinto zokutya okwenziweyo. Ubugcisa kunye nokuziqhelanisa]. UAnn Fr. Anesth. Ngo-1988; 7: 320-332. Jonga i-abstract.
16. Nemery, B. Ityhefu yentsimbi kunye neendlela zokuphefumla. Ukuphefumla kwe-Eur. J 1990; 3: 202-219. Jonga i-abstract.
17. Mehta, R. kunye noReilly, J. J. Amanqanaba eManganese kwisigulana sexesha elide esigcwele isigulo sokuzala: amandla e-haloperidol anetyhefu? Ingxelo yemeko kunye nokuphononongwa koncwadi. JPEN J Umzali. Isondlo sangaphakathi 1990; 14: 428-430. Jonga i-abstract.
18. UJanssens, J. kunye noVandenberghe, W. Dystonic behla ngeenyawo kwisigulana esine-manganism. Neurology 8-31-2010; 75: 835 (PubMed) (Umnqamlezo) Jonga i-abstract.
19. El-Attar, M., Said, M., El-Assal, G., Sabry, NA, Omar, E., kunye no-Ashour, L.Serum trace trace element level in COPD isiguli: unxibelelwano phakathi kokulandela into yokuxhasa kunye nexesha umoya ongenisa oomatshini kuvavanyo olulawulwa ngokungenamkhethe. Unyango. Ngo-2009; 14: 1180-1187. Jonga i-abstract.
20. Davidsson, L., Cederblad, A., Lonnerdal, B., kunye neSandstrom, B. Iziphumo zezinto zokutya ezizodwa ekufunxweni kwe manganese ebantwini. NdinguJ J weeKlinikhi ngo-1991; 54: 1065-1070. Jonga i-abstract.
21. UKim, uEA, uCheong, uH., UJo, uK. D., uShin, uJ. UH., ULee, uJ. Neurotoxicology 2007; 28: 263-269. Jonga i-abstract.
22. UJiang, Y. kunye noZheng, W.Iityhefu zentliziyo kwimithambo ye manganese. Cardiovasc. Ityhefu ye-2005; 5: 345-354. Jonga i-abstract.
23. UZiegler, U. E., Schmidt, K., Keller, H. P., kunye noThiede, A. [Unyango lwamanxeba anganyangekiyo ngokunxitywa kwealginate equkethe ikhalsiyam zinc kunye nemanganizi]. I-Fortschr, iMvelaphi yeMed. Ngo-2003; 121: 19-26. Jonga i-abstract.
24. UGerber, G. B., Leonard, A., kunye noHantson, P. Carcinogenicity, mutagenicity kunye teratogenicity yeemanganese compounds. Uhlalutyo Rev Oncol Hematol. Ngo-2002; 42: 25-34. Jonga i-abstract.
25. UFinley, J. W. Manganese ukufunxwa kunye nokugcinwa kwabafazi abancinci kunxulunyaniswa noxinzelelo lwe-serum ferritin. NdinguJ J Nutrition 1999; 70: 37-43. Jonga i-abstract.
26. UMcMillan, D. E. Imbali emfutshane yetyhefu ye-neurobehaisheral yetyhefu yemanganizi: eminye imibuzo engaphendulwanga. I-Neurotoxicology 1999; 20 (2-3): 499-507. Jonga i-abstract.
27. IBenevolenskaia, LI, Toroptsova, NV, Nikitinskaia, OA, Sharapova, EP, Korotkova, TA, Rozhinskaia, LI, Marova, EI, Dzeranova, LK, Molitvoslovova, NN, Men'shikova, LV, Grudinina, OV, Lesniak, OM, I-Evstigneeva, i-LP, i-Smetnik, i-VP, i-Shestakova, i-IG, ne-Kuznetsov, i-SI [i-Vitrum osteomag ekuthinteleni i-osteoporosis kwabasetyhini abasemva kwamadoda: iziphumo zolingo oluvulekileyo lokuthelekisa]. Umkhombe. Ngo-2004; 76: 88-93. Jonga i-abstract.
28. URandhawa, R. K. kunye noKawatra, B. L. Iziphumo zokutya kwiprotein ekufunxweni nasekugcinweni kweZn, Fe, Cu kunye noMn kumantombazana angaphambi kwexesha lokufikisa. UNahrung 1993; 37: 399-407. Jonga i-abstract.
29. URivera JA, uGonzález-Cossío T, uFlores M, et al. Unyango oluninzi lwe-micronutrient lonyusa ukukhula kweentsana zaseMexico. NdinguJ oNyango lweeKlinikhi. NgoNovemba 2001; 74: 657-63. Jonga i-abstract.
30. UDobson AW, uErikson KM, u-Aschner M. Manganese neurotoxicity. UAnn N Y Acad Sci 2004; 1012: 115-28. Jonga i-abstract.
31. Amagunya KM, Smith-Weller T, Franklin GM, et al. Ubungozi besifo sikaParkinson esidibene ne-iron yokutya, i-manganese, kunye nokunye ukutya kwezondlo. I-Neurology 2003; 60: 1761-6 .. Jonga okungafakwanga.
32. U-Lee JW. Ukunxila kweManganese. IArch Neurol 2000; 57: 597-9 .. Jonga i-abstract.
33. I-Das A Jr, iHammad TA. Ukusebenza kwendibaniselwano ye-FCHG49 glucosamine hydrochloride, TRH122 ephantsi yemolekyuli yesodium chondroitin sulphate kunye ne-manganese ascorbate kulawulo lweedolo osteoarthritis. I-Osteoarthritis Cartilage 2000; 8: 343-50. Jonga i-abstract.
34. Ukutya kunye neBhodi yeZondlo, iZiko lezeMpilo. Ukungeniswa kwereferensi yokutya kwiVitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, kunye neZinc. IWashington, DC: ICandelo leSizwe lezeMfundo, 2002. Iyafumaneka kwi: www.nap.edu/books/0309072794/html/.
35. I-Leffler CT, iPhilippi AF, iLeffler SG, et al. I-Glucosamine, i-chondroitin, kunye ne-manganese ascorbate yezifo ezidibeneyo zokudodobala kwedolo okanye umva ophantsi: isifundo somqhubi esilawulwa ngokungahleliwe, esingaboniyo, esilawulwa yi-placebo. IMil Med 1999; 164: 85-91. Jonga i-abstract.
36. Freeland-Amangcwaba JH. Imanganizi: sisinongo esidingekayo ebantwini. Isondlo namhlanje 1988; 23: 13-9.
37. Freeland-Amangcwaba JH, Turnlund JR. Ukudityaniswa kunye nokuvavanywa kweendlela, iiphelo kunye neparadigms ye-manganese kunye ne-molybdenum izindululo malunga nokutya. J Nutriti 1996; 126: 2435S-40S. Jonga i-abstract.
38. IPenland JG, uJohnson PE. I-calcium yokutya kunye nemiphumo ye-manganese kwiimpawu zokuhamba kwexesha. NdinguJ Obstet Gynecol 1993; 168: 1417-23. Jonga i-abstract.
39. IMoghissi KS. Umngcipheko kunye nezibonelelo zezongezelelo zesondlo ngexesha lokukhulelwa. I-Obstet Gynecol 1981; 58: 68S-78S. Jonga i-abstract.
40. ODell BL. Ukudibana kwezimbiwa okunxulumene neemfuno zezondlo. J Amanqatha 1989; 119: 1832-8. Jonga i-abstract.
41. UKrieger D, uKrieger S, uJansen O, et al. I-Manganese kunye ne-hepatic encephalopathy. ILancet 1995; 346: 270-4. Jonga i-abstract.
42. Freeland-Amangcwaba JH, Lin PH. Ukufunyanwa kweplasma yemanganizi njengoko kuchatshazelwe yimithwalo yomlomo yemanganizi, ikhalsiyam, ubisi, iphosphorus, ubhedu kunye ne-zinc. J NdinguColl Nutriti 1991; 10: 38-43. Jonga i-abstract.
43. I-Strause L, uSaltman P, uSmith KT, et al. Ukuphulukana nethambo lomqolo kubafazi be-postmenopausal abongezwe nge-calcium kunye nokulandelwa kwezimbiwa. J Amanqatha 1994; 124: 1060-4. Jonga i-abstract.
44. IHauser RA, iZesiewicz TA, uMartinez C, et al. Ukudibana kwegazi le-manganese kunye nengqondo yokutshintsha kwemagneti yokujonga imeko kwizigulana ezinesifo sesibindi. Ngaba uJ Neurol Sci 1996; 23: 95-8. Jonga i-abstract.
45. IBarrington WW, iAngle CR, uWillcockson NK, et al. Umsebenzi we-Autonomic kubasebenzi be-manganese alloy. Indawo yokuhlala ngo-1998; 78: 50-8. Jonga i-abstract.
46. UZhou JR, Erdman JW Jr.Phytic acid kwimpilo nakwizifo. Crit Rev Ukutya iSci Nutriti 1995; 35: 495-508. Jonga i-abstract.
47. IHansten PD, Uphondo JR. UHalsten noHorn's Unxibelelwano lokuSebenzisa iziyobisi kunye noLawulo. IVancouver, CAN: Appl Therapeutics, 1999.
48. I-DS encinci. Iziphumo zeziyobisi kuvavanyo lweelebhu zeklinikhi 4th ed. IWashington: I-AACC Press, ngo-1995.
49. Iinyani ngeziyobisi kunye nokuThelekisa. Olin BR, ed. I-St. Louis, MO: Iinyani kunye nokuThelekisa. (ihlaziywa ngenyanga).
50. UMcEvoy GK, ed. Ulwazi lwe-AHFS yeziyobisi. I-Bethesda, MD: Umbutho waseMelika we-Health-System Pharmacists, 1998.

Ukuhlaziywa okokugqibela - 04/24/2020